G1 Therapeutics, Inc. (NASDAQ:GTHX) Q2 2023 Earnings Call Transcript

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q2 2023 Earnings Call Transcript August 2, 2023

G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.92 EPS, expectations were $0.17.

Operator: Good day, and thank you for standing by. Welcome to the G1 Second Quarter Financial Results Conference Call. [Operator Instructions]. I would now like to hand the conference over to the speaker today, Will Roberts. Please go ahead.

William Roberts: Thank you, Jade. Good morning, everyone, and...